Want to see IN:BAFNAPH full AI Analyst Report?

Bafna Pharmaceuticals Limited (BAFNAPH) Financial Statements

0 Followers

Bafna Pharmaceuticals Limited Financial Overview

Bafna Pharmaceuticals Limited's market cap is currently ₹4.91B. The company's EPS TTM is ₹4.69; its P/E ratio is 42.77; Bafna Pharmaceuticals Limited is scheduled to report earnings on May 29, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 1.51B	₹ 1.46B	₹ 1.52B	₹ 1.15B	₹ 851.40M
Gross Profit	₹ 201.42M	₹ 168.77M	₹ 452.15M	₹ 387.56M	₹ 338.60M
Operating Income	₹ 98.75M	₹ 62.87M	₹ 237.66M	₹ 103.92M	₹ 64.98M
EBITDA	₹ 159.48M	₹ 117.73M	₹ 146.34M	₹ 189.88M	₹ 112.34M
Net Income	₹ 111.00M	₹ 41.52M	₹ 73.48M	₹ 113.38M	₹ 52.16M
Balance Sheet
Cash & Short-Term Investments	₹ 20.25M	₹ 34.33M	₹ 13.96M	₹ 78.09M	₹ 194.00K
Total Assets	₹ 1.76B	₹ 1.53B	₹ 1.48B	₹ 1.30B	₹ 901.45M
Total Debt	₹ 374.33M	₹ 281.99M	₹ 243.89M	₹ 229.24M	₹ 110.59M
Net Debt	₹ 354.09M	₹ 247.66M	₹ 229.93M	₹ 151.14M	₹ 110.40M
Total Liabilities	₹ 793.83M	₹ 682.73M	₹ 668.43M	₹ 561.29M	₹ 281.81M
Stockholders' Equity	₹ 961.50M	₹ 848.07M	₹ 808.39M	₹ 734.55M	₹ 619.64M
Cash Flow
Free Cash Flow	₹ -130.76M	₹ -23.31M	₹ -60.93M	₹ -32.66M	₹ 21.87M
Operating Cash Flow	₹ 118.27M	₹ 195.29M	₹ 94.85M	₹ 49.52M	₹ 97.28M
Investing Cash Flow	₹ -224.69M	₹ -213.02M	₹ -150.54M	₹ -74.93M	₹ -65.44M
Financing Cash Flow	₹ 92.35M	₹ 38.09M	₹ -8.45M	₹ 101.77M	₹ -48.15M

Currency in INR

Bafna Pharmaceuticals Limited Earnings and Revenue History

Income Statement >

Bafna Pharmaceuticals Limited Debt to Assets

Balance Sheet >

Bafna Pharmaceuticals Limited Cash Flow

Cash Flow >

Bafna Pharmaceuticals Limited Forecast EPS vs Actual EPS

Earnings >